Zero Tolerance Anti-Doping Newsletter
Volume 2, Issue 2 - March 2005
In This Issue
USA Track & Field CEO Craig A. Masback and USATF President Bill Roe developed the plan in concert with the USATF Board of Directors in October 2003 by combining existing programs and USATF priorities with ambitious new initiatives. "Zero Tolerance" focuses on three goals: increasing efforts to catch and punish cheaters; expanding educational efforts and focusing the message on the theme that cheating is wrong and cheaters will be caught; and taking a more visible role on these issues.
For the first time in its history, the IAAF conveyed a joint meeting between representatives of the Athletes', Coaches and Medical and Anti-Doping Commissions in Monte Carlo.
Past and active athletes, coaches, medical experts, anti-doping officials and IAAF staff comprised the nearly 60 representatives invited to participate, included USATF's Executive Director of Elite Athlete Programs Michael Conley.
The bottom line of the joint meeting was that all parties were willing to be pro-active in the first against doping although each one inevitably has a different perspective on the topic. For example - the representatives from the Athletes' Commission announced their total commitment to Clean Sport, and supported the strict policy of USATF regarding suspensions for life for a first-time steroid offense. However, the athletes also requested greater transparency and guidance from the IAAF regarding anti-doping rules and procedures.
Important Notice to Athletes in the IAAF OOC Testing Pool:
Recently, the IAAF amended their testing protocol regarding Out of Competition (no advance notice testing) in several key areas. While we have not received official word about this procedural changes, many athletes have contacted USATF in regards to these topics and we want everyone to be aware of what to expect.
USATF strongly recommends that athletes take into consideration these changes when they are notified of an IAAF missed test by responding by the deadline in detail regarding your whereabouts on the day in question. USATF understands the frustration that you as athletes are encountering regarding this procedure. We are working with the IAAF to try to amend the protocol, but until that time, we need all athletes to continue to be compliant with the current IAAF rules and procedures, including a list of athlete's rights when they are chosen for testing.
If you have questions or concerns, please contact USATF's Melissa Beasley at 317-261-0478 x335.
Athlete Advisory - from the desk of Terrence Madden, USADA CEO
On January 25, 2005, the World Anti-Doping Agency (WADA) List Committee considered the status of Yasmin, an oral contraceptive. On January 27, 2005, WADA notified USADA that the medication, Yasmin, is allowed in- or out-of-competition, effectively immediately.
Previously, USADA had informed athletes that the medication was prohibited based on the presences of the diuretic drospirenone. WADA's decision is a positive one for athletes. American athletes who compete around the world and use Yasmin will not be subject to a doping violation for the presence of drospirenone.
For the athletes previously impacted by the Yasmin's prohibited status, USADA thanks you for your supporting their anti-doping efforts.
On October 22, 2004, President George W. Bush signed into law S. 2195, the Anabolic Steroid Control Act of 2004. The Act adds certain anabolic steroid precursors to the list of anabolic steroids that are classified as controlled substances and are illegal without a medical prescription. Effective January 20, 2005:
Two of the most notable precursors identified in the act include androstenedione and dihydrotestosterone (also known as 1-testosterone).
For more information or a complete copy of the Act, visit www.casper207.com.
USADA announced their final testing numbers for 2004 - performing a total of 8,051 doping control testing in 69 Olympic, Paralympic and Pan American sports, including 7,630 domestic tests. Out-of-Competition (OOC) testing comprised approximately 58 percent (4,447) of the domestic tests USADA conducted in 2004. In the fourth quarter alone, USADA conducted 1,083 domestic tests, including 708 OOC tests. For track and field, 1,618 total tests were conducted in 2004, which includes OOC and event testing.
Athletes can now get drug reference information from the U.S. Anti-Doping Agency Drug Reference Online (DRO) 24-hours a day, 7-days a week at www.usantidoping.org/dro/. In October 2004, USADA launched its DRO to serve as a supplement for athletes who have questions about medications on weekends or after USADA office hours.
The DRO provides easily accessible and accurate information on whether specific U.S. pharmaceutical products are permitted for us by athletes. Some over-the-counter medicinal products are included in the database.
The DRO provides the status of the pharmaceutical from the WADA 2004 Prohibited List and applies ONLY to the formulations used in the United States. A DRO search will classify a drug or a formulation (combination of medications) based on the strictest status of any one component.
USADA recently posted the 2005 USADA/WADA Prohibited Substances and Prohibited Methods Wallet Card online for athletes, coaches and trainers to download and print for reference. The Wallet Cards will also be available at various Visa Championship Series Events throughout the indoor and outdoor season and will be mailed to all athletes currently in the USADA Out of Competition Testing Pool.
Visit the USADA website for the updated Wallet Cards (PDF).
Please note that the list online is not complete and is subject to change. USATF recommends that athletes call the USADA Drug Reference line with questions about medications not listed on the Wallet Card at 1-800-233-0393.
As you may know, the World Anti-Doping Agency (WADA) recently announced significant changes for the 2005 List of Prohibited Substances and Prohibited Methods of Doping.
Below you will find a summary of these significant changes as well as the link to the WADA website. USATF strongly recommends that you review the new rules and policies for 2005, as they went into effect January 1, 2005.
Remember that a substance does not have to be listed on the WADA list for it to be banned as WADA, USADA, USOC, IAAF, and USATF all recognize 'related substances' as banned as well.
SUMMARY OF SIGNIFICANT INFORMATION FOR 2005
S1. Anabolic Agents
a. Nine substances have been added to the list of examples.
b. For endogenous steroids, the T/E ratio, which prompts an investigation, has been changed from 6:1 to 4:1. (Please note that a doping case can be put forward if laboratory evidence supports the case even at T/E ratios less than 4:1.)
S2. Hormones and Related Substances
a. The following substances are prohibited in men and women: erythropoietin (EPO), human growth hormone (hGH), insulin-like growth factor (IGF-1), mechano growth factor (MGFs), gonadotrophins (LH, hCG), insulin and corticotrophins.
S3. Beta-2 agonists (Asthma medications)
a. All beta-2 agonists are now prohibited in- and out-of-competition. Please note that this means that athletes who use beta-2 agonists for asthma and are tested at either an event or out-of-competition test will be screened for these substances and therefore must have an approved ATUE on file with USADA and the IAAF.
b. Salbutamol (albuterol, levalbuterol), salmeterol, terbutaline, and formoterol are permitted by inhalation only and only with a completed Abbreviated Therapeutic Use Exemption (ATUE).
c. A salbutamol (albuterol) concentration greater than 1,000 ng/mL is a doping violation (in- or out-of-competition and with or without an Abbreviated TUE) unless the athlete can prove the concentration is due to therapeutic use by inhalation.
S4. Agents with Anti-Estrogenic Activity
a. Substances that were previously prohibited in men are NOW prohibited in both men and women. A partial list of examples is provided for each category. New examples added to this category include anastrozole, letrozole, aminogluthetimide, formestane, testolactone, raloxifene, toermifene, fulvestrant.
S5. Diuretics and other Masking Agents
a. Finasteride (Propecia, Proscar) and other 5-alpha reductase inhibitors have been added as prohibited substances.
b. A TUE is not valid if an athlete's urine contains a diuretic in association with threshold or sub-threshold levels of a Prohibited Substance.
a. Stimulant rules are unchanged and all are prohibited in-competition.
a. Fentanyl and its derivatives have been added to the Prohibited List.
b. Eleven narcotics are specifically prohibited in-competition.
c. Local anesthetics are permitted unless specifically listed.
a. Prohibited in-competition in all sports.
b. Rules apply only in-competition. Glucocorticosteroids are not tested for out-of-competition.
c. Systemic administration is prohibited (intramuscular, intravenous, oral, and rectal administration).
d. Local injection, intra-articular injection, inhalation, iontophoresis, eye drops, ear drops, and nasal sprays etc. require the submission of an acceptable Abbreviated TUE.
e. Dermal (topical on skin) applications are allowed and do not require an Abbreviated TUE.
S10. Miscellaneous Comments
a. Insulin is prohibited as a Peptide Hormone - athletes must file a standard TUE.
b. Vicks inhaler is still prohibited due to L-methamphetamine.
c. The substances included in the 2005 Monitoring List (bupropion, caffeine, phenylephrine, phenylpropanolamine, pipradrol, pseudoephedrine, synephrine and the morphine/codeine ratio) are not considered prohibited substances.
Questions should be directed to the USADA Drug Reference Line at 1-800-233-0393 or online at www.usantidoping.org/dro/. For the 2005 Prohibited List of Substances and Methods (PDF) visit the WADA website.
USADA recently made significant changes to its publication USADA Protocol for Olympic Movement Testing - specifically to Annex E - regarding the American Arbitration Association Supplementary Procedures for Arbitration of Olympic Sport Doping Disputes.
USATF strongly recommends that all athletes and athlete support personnel review the newly published protocol (PDF) by visiting the USADA website.
|April 3||Pan Am Race Walk Cup Trials, Hauppage, NY|
|April 9||Texas Relays, Austin, TX|
|April 17||Mt. SAC Relays, Walnut, CA|
|April 23||Kansas Relays, Lawrence, KS|
|April 30||Drake Relays, Des Moines, IA|
|April 30||Penn Relays, Philadephia, PA|
|May 7||Modesto Relays, Modesto, CA|
|May 22||Track & Field Invitational, Carson, CA|
|May 30||Payton Jordan U.S. Open, Palo Alto, CA|
|May 30||Bolder Boulder 10 km, Boulder, CO|
|June 4||Nike Prefontaine Classic, Eugene, OR|
|June 8-11||NCAA Division I Track & Field Championships, Sacramento, CA|
|June 23-26||USA Outdoor Track & Field Championships, Carson, CA|